Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis
Stefanie Schreiber, Marwa Al‐Dubai, Stefan Vielhaber, Lora Lefterova, Sascha Dietrich, Tobias Ruck, Sven G. Meuth, Denise Walther, Dimitrios Mougiakakos
Topics & Concepts
Myasthenia gravisBispecific antibodyRefractory (planetary science)MedicineAntibodyImmunologyCancer researchBiologyMonoclonal antibodyAstrobiologyMyasthenia Gravis and ThymomaCancer Treatment and Pharmacology